Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Norovirus in Transplant Recipients
NCT03395405Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in norovirus gastroenteritis, sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2018; status: completed.
02
Drugs
nitazoxanide
03
Conditions
norovirus gastroenteritis
Beyond the preview
Go deeper on NCT03395405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395405.